Delivery Order SPE2DE24D0013-SPE2D625F2D3Y

Award Date 4/9/25
Potential Completion Date 4/16/25
Potential Value $3.5K
Federal Agency
Medical Supply Chain
Awardee
Cepheid
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Sunnyvale, CA 94089, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, by the Defense Logistics Agency (DLA). The contract, valued at $2,208.00, is a firm fixed-price delivery order with no set-aside designation. Cepheid will provide the DLA with its GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services for detecting a variety of infectious diseases, including COVID-19, influenza, and sexually transmitted diseases....
This is a federal contract award from the Defense Logistics Agency (DLA) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The award, valued at $16,320.00, is a firm fixed-price delivery order contract with no set-aside designation. The contract is for the provision of Cepheid's GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services to support the detection of infectious diseases such as COVID-19, influenza, and respiratory...
This is a federal contract award from the Defense Logistics Agency (DLA) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract, worth $13,600.00, is a firm fixed-price delivery order with no set-aside designation. Cepheid will provide the DLA with GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services for detecting infectious diseases such as COVID-19, influenza, and respiratory syncytial virus (RSV). This award is part of...
This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The award, valued at $1,054.20, is a firm fixed-price delivery order contract with no set-aside designation. The contract requires Cepheid to provide the DLA with its GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services. These solutions are used to detect a...
This federal contract award, valued at $14,448.00, was issued by the Defense Logistics Agency (DLA) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract is a delivery order under a larger Indefinite Delivery Vehicle (IDV) and has no set-aside designation. Cepheid will provide the DLA with its GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services for detecting infectious diseases such as COVID-19, influenza, and...
This is a federal contract awarded by the Defense Logistics Agency (DLA) to Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions. The contract, valued at $4,080.00, is a firm fixed-price delivery order that provides the DLA with Cepheid's GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services. These products and services are used for detecting a variety of infectious diseases, including COVID-19, influenza, and respiratory...
This is a federal contract award to Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions, by the Defense Logistics Agency (DLA). The contract, valued at $4,539.30, is a firm fixed-price delivery order with no set-aside designation. Cepheid will provide the DLA with its GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services for detecting infectious diseases such as COVID-19, influenza, respiratory syncytial virus (RSV),...
This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, by the Defense Logistics Agency (DLA), an agency within the U.S. Department of Defense. The contract, valued at $5,440.00, is a firm fixed-price delivery order for the provision of GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services to detect infectious diseases such as COVID-19, influenza, and respiratory syncytial virus (RSV). The contract has...
This federal contract award, worth up to $204,000.00, was issued by the Defense Logistics Agency (DLA) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract is a firm fixed-price delivery order, with no set-aside designation. Cepheid will provide the agency with its GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services. These solutions enable the rapid detection and diagnosis of various infectious diseases, including...
This is a firm fixed-price delivery order federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, by the Defense Logistics Agency (DLA) with a total ceiling value of $3,465.00. The contract is for the provision of GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services to support the detection of infectious diseases such as COVID-19, influenza, and other clinical conditions. The contract is not associated with a...
  • SPE2DE24D0013
    Indefinite Delivery Contract
  • SPE2DE24D0013-SPE2D625F2D3Y
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions. The contract, valued at $3,456.00, is a firm fixed-price delivery order with no set-aside designation. Cepheid will provide the DLA with its GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services for detecting infectious diseases such as COVID-19, influenza, and respiratory syncytial virus (RSV). This contract is part of Cepheid's broader portfolio of federal contracts, including Indefinite Delivery Vehicles (IDVs) with the Department of Veterans Affairs and the Indian Health Service, which enable these agencies to continuously procure Cepheid's molecular diagnostic solutions.

Generated 7/9/25, 10:02 AM